These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9673102)

  • 1. [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].
    Lando C; Hagmar L; Bonassi S
    Med Lav; 1998; 89(2):124-31. PubMed ID: 9673102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
    Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
    Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.
    Hagmar L; Brøgger A; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Res; 1994 Jun; 54(11):2919-22. PubMed ID: 8187078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
    Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
    Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    Int J Hyg Environ Health; 2001 Oct; 204(1):43-7. PubMed ID: 11725344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes.
    Bolognesi C; Abbondandolo A; Barale R; Casalone R; Dalprà L; De Ferrari M; Degrassi F; Forni A; Lamberti L; Lando C; Migliore L; Padovani P; Pasquini R; Puntoni R; Sbrana I; Stella M; Bonassi S
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):249-56. PubMed ID: 9107430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    IARC Sci Publ; 2004; (157):207-15. PubMed ID: 15055297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations and SCEs as biomarkers of cancer risk.
    Norppa H; Bonassi S; Hansteen IL; Hagmar L; Strömberg U; Rössner P; Boffetta P; Lindholm C; Gundy S; Lazutka J; Cebulska-Wasilewska A; Fabiánová E; Srám RJ; Knudsen LE; Barale R; Fucic A
    Mutat Res; 2006 Aug; 600(1-2):37-45. PubMed ID: 16814813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.
    Bonassi S; Znaor A; Ceppi M; Lando C; Chang WP; Holland N; Kirsch-Volders M; Zeiger E; Ban S; Barale R; Bigatti MP; Bolognesi C; Cebulska-Wasilewska A; Fabianova E; Fucic A; Hagmar L; Joksic G; Martelli A; Migliore L; Mirkova E; Scarfi MR; Zijno A; Norppa H; Fenech M
    Carcinogenesis; 2007 Mar; 28(3):625-31. PubMed ID: 16973674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronuclei in peripheral blood lymphocytes as a possible cancer risk biomarker: a cohort study of occupationally exposed workers in Croatia.
    Znaor A; Fucić A; Strnad M; Barković D; Skara M; Hozo I
    Croat Med J; 2003 Aug; 44(4):441-6. PubMed ID: 12950148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.
    Hagmar L; Bonassi S; Strömberg U; Mikoczy Z; Lando C; Hansteen IL; Montagud AH; Knudsen L; Norppa H; Reuterwall C; Tinnerberg H; Brogger A; Forni A; Högstedt B; Lambert B; Mitelman F; Nordenson I; Salomaa S; Skerfving S
    Mutat Res; 1998 Sep; 405(2):171-8. PubMed ID: 9748557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
    Liou SH; Lung JC; Chen YH; Yang T; Hsieh LL; Chen CJ; Wu TN
    Cancer Res; 1999 Apr; 59(7):1481-4. PubMed ID: 10197617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage.
    Mutat Res; 1990 Jul; 241(3):325-37. PubMed ID: 2366811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Engholm G; Storm HH; Tryggvadóttir L; Gislum M; Hakulinen T; Bray F
    Acta Oncol; 2010 Jun; 49(5):578-607. PubMed ID: 20491524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic damage in pathology anatomy laboratory workers exposed to formaldehyde.
    Costa S; Coelho P; Costa C; Silva S; Mayan O; Santos LS; Gaspar J; Teixeira JP
    Toxicology; 2008 Oct; 252(1-3):40-8. PubMed ID: 18721846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic biomarkers.
    Norppa H
    IARC Sci Publ; 2004; (157):179-205. PubMed ID: 15055296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe.
    Boffetta P; van der Hel O; Norppa H; Fabianova E; Fucic A; Gundy S; Lazutka J; Cebulska-Wasilewska A; Puskailerova D; Znaor A; Kelecsenyi Z; Kurtinaitis J; Rachtan J; Forni A; Vermeulen R; Bonassi S
    Am J Epidemiol; 2007 Jan; 165(1):36-43. PubMed ID: 17071846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage.
    Brøgger A; Hagmar L; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Genet Cytogenet; 1990 Mar; 45(1):85-92. PubMed ID: 2302690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of intermediate endpoints in environmental and occupational health.
    Knudsen LE; Hansen AM
    Int J Hyg Environ Health; 2007 May; 210(3-4):461-70. PubMed ID: 17321211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.